Ovid Technologies Field Guide

Computer Retrieval of Information on Scientific Projects (CRSP)


Scope

Computer Retrieval of Information on Scientific Projects provides information about research projects funded or supported by the U.S. Public Health Service (PHS). Most of this research falls within the categories of extramural projects, grants, contracts and cooperative agreements conducted primarily by non-federal institutions and funded by the National Institutes of Health (NIH). CRSP is a unique source of biomedical information which can be used to reveal trends in biomedical research, methodologies and techniques before they appear in the published literature.


General Information

Producer
Chief, Research Documentation Section
NIH, Division of Research Grants
Westwood Building, 5333 Westbard Avenue
Bethesda, MD 20892
Website: http://www.grg.nih.gov

Years of Coverage
Fiscal year 1986 to the current month

Default fields for unqualified searches
TI, AB, MJ, MN

All Display/Print fields
AN, UP, RT, PN, SP, TI, AU, IN, AD, TA, AC, AW, FY, SU, RG, GL, FT, AB, MJ, MN

Default Display/Print Fields
AN, UP, RT, PN, SP, TI, AU, IN, AD, TA, AC, AW, FY, SU, RG, GL, FT, AB, MJ, MN

Update Frequency
Monthly

Searching the CRSP fields

The following alphabetical list provides the two-letter label, the relevant alias, and an example for each Computer Retrieval of Information on Scientific Projects database field.

=====        ============
Label        Name/Example
=====        ============

ab           Abstract [Word Indexed]
example:     animal resource management.ab.

ac           Activity Code [Word Indexed]
example:     f05.ac.

ad           Address of Principal Investigator [Word Indexed]
example 1:   san antonio tx.ad.
example 2:   tx.ad.

an           Accession Number [Phrase Indexed]
example:     4922419.an.

au           Prinicipal Investigator [Phrase and Word Indexed]
example 1:   troshev orlin s.au.
example 2:   troshev.au.

aw           Award Amount [Word Indexed]
example:     000373901.aw.

de           Descriptor (from MJ and MN fields)
example 1:   statistics biometry.de.
example 2:   18164255.de.

ft           Future Years [Word Indexed]
example:     "4".ft.

fy           Fiscal Year [Word Indexed]
example:     1996.fy.

gl           Geographic Location [Word Indexed]
example 1:   texas.gl.
example 2:   "044".gl.

in           Performing Organization [Word Indexed]
example:     southwest foundation.in.

mj           Major Descriptor [Phrase and Word Indexed]
example 1:   cardiovascular disorder.mj.
example 2:   05710209.mj.

mn           Minor Descriptor [Phrase and Word Indexed]
example 1:   blood chemistry.mn.
example 2:   06335558.mn.

pn           Project Number [Phrase Indexed]
example:     p01rr09919-01.pn.

rg           Initial Review Group [Word Indexed]
example:     icp.rg.

rt           Record Type [Word Indexed]
example:     subproject.rt.

sp           Subproject Number [Word Indexed]
example:     9001.sp.

su           Supporting Organization [Word Indexed]
example:     tw.su.

ta           Type of Award [Word Indexed]
example 1:   new.ta.
example 2:   "1".ta.

ti           Title of Project [Word Indexed]
example:     retroviral vaccine.ti.

up           Update Code [Phrase Indexed]
example:     9702.up.

Computer Retrieval of Information on Scientific Project Limits

The following limits are available from the Limit menu on the Main Search Screen:

Popular Command and Sentence Limits:


Limit Name             Example

Fiscal Year
Command Syntax:        ..l/4 fy=1994

Record Type
Command Syntax:        ..l/3 rt=su
Sentence Syntax:       limit 3 to "parent or single"
                       limit 3 to subproject


Change to CRSP from another database

Command Syntax:        ..c/crsp
Sentence Syntax:       use crsp


Sample CRSP Documents

<1>
Accession Number
  6492861.
Update Code
  9702
Record Type
  SUBPROJECT (SU).
Project Number
  U01TW00331-02S1.
Subproject Number
  0004.
Title of Project/Subproject
  PERUVIAN MEDICINAL PLANT SOURCES OF NEW PHARMACEUTICALS.;
  SUBPROJECT TITLE: PHYTOCHEMISTRY.
Principal Investigator
  SUBPROJECT INVESTIGATOR: CORLEY, DAVID.
Performing Organization
  WASHINGTON UNIVERSITY.
Address of Principal Investigator
  WASHINGTON UNIVERSITY
  ONE BROOKINGS DR., CAM.  BOX 11
  ST LOUIS, MO 63130.
Type of Award
  GRANT: Supplement (3).
Activity Code
  U01.
Award Amount
  000320001;   (SUBPROJECT AWARD AMOUNT NOT AVAILABLE).
Fiscal Year
  1996.
Supporting Organization
  TW.
Initial Review Group
  Special Review Committee (all Institutes) (SRC).
Geographic Location
  Missouri (026).
Future Years
  0.
Abstract
  The value of screening plant extracts to the U.S.  pharmaceutical
  industry is the promise of finding patentable compounds to treat
  human diseases. Ethnobotanical rationale for selecting targeted
  plants allows a focused approach in finding compounds of phar
  maceutical interest The Phytochemistry Section of "Peruvian
  Medicinal Plants As Sources Of New Pharmaceuticals" provides the
  - sample text truncated -
Major Descriptor
  antiinfective-agent (07151132)
  antiinflammatory-agent (09446430)
  drug-screening-evaluation (09639394)

<2>
Accession Number
  6492528.
Update Code
  9702
Record Type
  PARENT OR SINGLE (PS).
Project Number
  U42RR11149-02.
Title of Project/Subproject
  NATIONAL GENE VECTOR LABORATORY.
Principal Investigator
  NABEL, GARY J.
Performing Organization
  UNIVERSITY OF MICHIGAN AT ANN ARBOR.
Address of Principal Investigator
  UNIVERSITY OF MICHIGAN MED CTR
  1150 WEST MEDICAL CENTER DRIVE
  ANN ARBOR, MI 48109-0650.
Type of Award
  GRANT: Noncompeting Continuation (5).
Activity Code
  U42.
Award Amount
  000777250.
Fiscal Year
  1996.
Supporting Organization
  RR.
Initial Review Group
  Special Review Committee (all Institutes) (SRC).
Geographic Location
  Michigan (023).
Future Years
  3.
Abstract
  (Adapted from the applicant`s abstract): A variety of gene transfer
  vectors will ultimately be required to develop successful gene
  therapies for human disease.  Each vector type requires specialized
  technology to optimize gene transfer and to address production
  issues.  Although initial efforts utilized viral vectors for human
  gene therapy, synthetic, non-viral gene delivery systems have shown
  promise in clinical use. Desirable features of these vectors
  include improved safety for direct gene transfer in vivo and
  simplified production.  This proposal is intended to support the
  - sample text truncated -
Major Descriptor
  biomedical-facility (04190946)
  gene-therapy (12548123)
  transfection-vector (40010135)
Minor Descriptor
  liposome (04183232)
  plasmid (12562978)
  gene-expression (12568024)
  genetic-enhancer-element (12576833)
  gold (18528252)
  DNA (21019742)
  nucleic-acid-sequence (21028337)
  cell-bank-registry (29355459)
  recombinant-DNA (40000310)

Revised 21 March, 1997